Suchergebnisse - "Gossec, Laure"

PubPharm (24)

1

Guselkumab provides durable improvement across psoriatic arthritis disease domains : post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

enthalten in: RMD open | 2024

von Coates, L. | Gossec, L. | Zimmermann, M. | +8

2

Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs : a systematic literature review and meta-analysis

enthalten in: Arthritis research & therapy | 2024

von Gossec, L. | Humphries, B. | Rutherford, M. | +3

3

Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis : 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study

enthalten in: Annals of the rheumatic diseases | 2023

von Ritchlin, C. | Coates, L. | McInnes, I. | +12

4

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment : a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

enthalten in: Lancet (London, England) | 2023

von McInnes, I. | Asahina, A. | Coates, L. | +13

CommentIn: Lancet. 2023 Jan 7;401(10370):2-3. - PMID 36495880

5

Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics : a multicentre randomised clinical trial

enthalten in: RMD open | 2022

von Beauvais, C. | Fayet, F. | Rousseau, A. | +16

6

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial

enthalten in: Annals of the rheumatic diseases | 2021

von Molto, A. | López-Medina, C. | Van den Bosch, F. | +20

CommentIn: Ann Rheum Dis. 2021 Nov;80(11):1367-1369. - PMID 34144966

7

Patients' safety skills assessment with biologics and JAK inhibitors : Update of the BioSecure questionnaire

enthalten in: Joint bone spine | 2021

von Beauvais, C. | Gaud-Listrat, V. | Sellam, J. | +7

8

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease : data from the COVID-19 Global Rheumatology Alliance physician-reported registry

enthalten in: Annals of the rheumatic diseases | 2020

von Gianfrancesco, M. | Hyrich, K. | Al-Adely, S. | +26

CommentIn: Ann Rheum Dis. 2021 Jun;80(6):e87. - PMID 32606044

9

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update

enthalten in: Annals of the rheumatic diseases | 2020

von Gossec, L. | Baraliakos, X. | Kerschbaumer, A. | +25

CommentIn: Ann Rheum Dis. 2022 Aug;81(8):e139. - PMID 32873555

10

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2019 update

enthalten in: Annals of the rheumatic diseases | 2020

von Smolen, J. | Landewé, R. | Bijlsma, J. | +44

CommentIn: Nat Rev Rheumatol. 2020 Mar;16(3):128. - PMID 32001826